|
ZNF347 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.030500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.888810E-01 |
| Normal-vs-Stage2 |
6.403700E-02 |
| Normal-vs-Stage3 |
2.74379999998242E-06 |
| Normal-vs-Stage4 |
1.98100000003976E-06 |
| Stage1-vs-Stage2 |
2.803600E-01 |
| Stage1-vs-Stage3 |
3.61020000000378E-05 |
| Stage1-vs-Stage4 |
1.160440E-04 |
| Stage2-vs-Stage3 |
8.265500E-02 |
| Stage2-vs-Stage4 |
4.780500E-02 |
| Stage3-vs-Stage4 |
5.556600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.594600E-04 |
| Normal-vs-AfricanAmerican |
6.623400E-03 |
| Normal-vs-Asian |
5.631800E-01 |
| Caucasian-vs-AfricanAmerican |
5.053800E-01 |
| Caucasian-vs-Asian |
6.401900E-02 |
| AfricanAmerican-vs-Asian |
5.982200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.624800E-04 |
| Normal-vs-Female |
1.202390E-02 |
| Male-vs-Female |
3.182200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.843720E-02 |
| Normal-vs-Age(41-60Yrs) |
8.578000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.84929999999373E-05 |
| Normal-vs-Age(81-100Yrs) |
1.782930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.745800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.909200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.918000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.655900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.812100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.662570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.098760E-01 |
| Normal-vs-Grade 2 |
2.748400E-01 |
| Normal-vs-Grade 3 |
5.61729999999372E-05 |
| Normal-vs-Grade 4 |
1.2599999998919E-07 |
| Grade 1-vs-Grade 2 |
1.036990E-01 |
| Grade 1-vs-Grade 3 |
6.382600E-04 |
| Grade 1-vs-Grade 4 |
8.20700000000452E-05 |
| Grade 2-vs-Grade 3 |
2.045400E-04 |
| Grade 2-vs-Grade 4 |
4.14270000004269E-06 |
| Grade 3-vs-Grade 4 |
2.025600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.355800E-01 |
| Normal-vs-ccB subtype |
1.205890E-04 |
| ccA subtype-vs-ccB subtype |
1.441760E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.236900E-03 |
| Normal-vs-N1 |
1.589540E-02 |
| N0-vs-N1 |
1.021960E-01 |
|
|
